Influenza-virus-induced signaling cascades: Targets for antiviral therapy?

Trends in Molecular Medicine

Volumn 9, Issue 2, 2003, Pages 46-52

  Ludwig, Stephan ^a   Planz, Oliver ^b   Pleschka, Stephan ^c   Wolff, Thorsten ^d  

^a HEINRICH HEINE UNIVERSITY   (Germany)

^b FEDERAL RESEARCH INSTITUTE FOR ANIMAL HEALTH   (Germany)

^c JUSTUS LIEBIG UNIVERSITY   (Germany)

^d ROBERT KOCH INSTITUTE   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

1 (5 ISOQUINOLINESULFONYL) 2 METHYLPIPERAZINE; 1,4 DIAMINO 1,4 BIS(2 AMINOPHENYLTHIO) 2,3 DICYANOBUTADIENE; AMANTADINE; ANTIVIRUS AGENT; BISINDOLYLMALEIMIDE; CAPPED RNA; DOUBLE STRANDED RNA; ENZYME INHIBITOR; HYDROQUINONE DERIVATIVE; I KAPPA B KINASE; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR; NON STRUCTURAL PROTEIN 1; OSELTAMIVIR; PHOSPHOROTHIOIC ACID DERIVATIVE; POLYMER; PROTEIN KINASE C; PROTEIN KINASE C INHIBITOR; PROTEINASE INHIBITOR; PROTON TRANSPORTING ADENOSINE TRIPHOSPHATASE INHIBITOR; QUINONE DERIVATIVE; RIBAVIRIN; RIMANTADINE; RNA POLYMERASE INHIBITOR; SIALIC ACID DERIVATIVE; SIALIDASE INHIBITOR; STAUROSPORINE; UNCLASSIFIED DRUG; VIRUS PROTEIN; ZANAMIVIR;

ANTIMICROBIAL THERAPY; CELL FUNCTION; DRUG TARGETING; HOST CELL; INFLUENZA; INFLUENZA VIRUS; NONHUMAN; PROTEIN FUNCTION; REVIEW; SIGNAL TRANSDUCTION; VIRUS REPLICATION; VIRUS VIRULENCE;

INFLUENZA VIRUS;

EID: 0037295292     PISSN: 14714914     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1471-4914(02)00010-2     Document Type: Review

References (50)

1. Simonsen, L. et al. (1997) The impact of influenza epidemics on mortality: introducing a severity index. Am. J. Public Health 87, 1944-1950
2. Taubenberger, J.K. et al. (2000) The 1918 influenza virus: a killer comes into view. Virology 274, 241-245
3. Hatta, M. and Kawaoka, Y. (2002) The continued pandemic threat posed by avian influenza viruses in Hong Kong. Trends Microbiol. 10, 340-344
4. Luscher-Mattli, M. (2000) Influenza chemotherapy: a review of the present state of art and of new drugs in development. Arch. Virol. 145, 2233-2248
5. Fleming, D.M. (2001) Managing influenza: amantadine, rimantadine and beyond. Int. J. Clin. Pract. 55, 189-195
6. Gubareva, L.V. et al. (2000) Influenza virus neuraminidase inhibitors. Lancet 355, 827-835
7. Dreitlein, W.B. et al. (2001) Zanamivir and oseltamivir: two new options for the treatment and prevention of influenza. Clin. Ther. 23, 327-355
8. McClellan, K. and Perry, C.M. (2001) Oseltamivir: a review of its use in influenza. Drugs 61, 263-283
9. Gubareva, L.V. et al. (1998) Evidence for zanamivir resistance in an immunocompromised child infected with influenza B virus. J. Infect. Dis. 178, 1257-1262
10. Gubareva, L.V. et al. (2002) Detection of influenza virus resistance to neuraminidase inhibitors by an enzyme inhibition assay. Antiviral Res. 53, 47-61
11. Ludwig, S. et al. (1999) A fatal relationship - influenza virus interactions with the host cell. Viral Immunol. 12, 175-196
12. Julkunen, I. et al. (2000) Inflammatory responses in influenza A virus infection. Vaccine 19, S32-S37
13. Geiss, G.K. et al. (2002) Cellular transcriptional profiling in influenza A virus-infected lung epithelial cells: the role of the nonstructural NS1 protein in the evasion of the host innate defense and its potential contribution to pandemic influenza. Proc. Natl. Acad. Sci. U. S. A. 99, 10736-10741
14. Toker, A. (1998) Signaling through protein kinase C. Front. Biosci. 3, D1134-D1147
15. Constantinescu, S.N. et al. (1991) Effects of protein kinase C inhibitors on viral entry and infectivity. FEBS Lett. 292, 31-33
16. 2+-independent mechanism. J. Immunol. 154, 2092-2103
17. Arora, D.J. and Gasse, N. (1998) Influenza virus hemagglutinin stimulates the protein kinase C activity of human polymorphonuclear leucocytes. Arch. Virol. 143, 2029-2037
18. + channels in respiratory epithelia. Proc. Natl. Acad. Sci. U. S. A. 97, 10282-10287
19. Root, C.N. et al. (2000) Entry of influenza viruses into cells is inhibited by a highly specific protein kinase C inhibitor. J. Gen. Virol. 81, 2697-2705
20. Widmann, C. et al. (1999) Mitogen-activated protein kinase: conservation of a three-kinase module from yeast to human. Physiol. Rev. 79, 143-180
21. Dong, C. et al. (2002) MAP kinases in the immune response. Annu. Rev. Immunol. 20, 55-72
22. 2-terminal kinase regulate RANTES production by influenza virus-infected human bronchial epithelial cells. J. Immunol. 164, 3222-3228
23. Ludwig, S. et al. (2001) Influenza virus-induced AP-1-dependent gene expression requires activation of the JNK signaling pathway. J. Biol. Chem. 276, 10990-10998
24. Pleschka, S. et al. (2001) Influenza virus propagation is impaired by inhibition of the Raf/MEK/ERK signalling cascade. Nat. Cell Biol. 3, 301-305
25. Karin, M. et al. (1997) AP-1 function and regulation. Curr. Opin. Cell Biol. 9, 240-246
26. Ludwig, S. et al. (2002) The influenza A virus NS1 protein inhibits activation of Jun N-terminal kinase (JNK) and AP-1 transcription factors. J. Virol. 76, 11166-11171
27. Stark, G.R. et al. (1998) How cells respond to interferons. Annu. Rev. Biochem. 67, 227-264
28. Planz, O. et al. (2001) MEK-specific inhibitor U0126 blocks spread of Borna disease virus in cultured cells. J. Virol. 75, 4871-4877
29. Barber, S.A. et al. (2002) Visna virus-induced activation of MAPK is required for virus replication and correlates with virus-induced neuropathology. J. Virol. 76, 817-828
30. Luo, H. et al. (2002) Coxsackievirus B3 replication is reduced by inhibition of the extracellular signal-regulated kinase (ERK) signaling pathway. J. Virol. 76, 3365-3373
31. Hiscott, J. et al. (2001) Hostile takeovers: viral appropriation of the NF-κB pathway. J. Clin. Invest. 107, 143-151
32. Chu, W.M. et al. (1999) JNK2 and IKKβ are required for activating the innate response to viral infection. Immunity 11, 721-731
33. Flory, E. et al. (2000) Influenza virus-induced NF-κB-dependent gene expression is mediated by overexpression of viral proteins and involves oxidative radicals and activation of IκB kinase. J. Biol. Chem. 275, 8307-8314
34. Wang, X. et al. (2000) Influenza A virus NS1 protein prevents activation of NF-κB and induction of α/β interferon. J. Virol. 74, 11566-11573
35. Chomik, M. (1981) Interferon induction by influenza virus: significance of neuraminidase. Arch. Immunol. Ther. Exp. 29, 109-114
36. Houde, M. and Arora, D.J. (1990) Stimulation of tumor necrosis factor secretion by purified influenza virus neuraminidase. Cell. Immunol. 129, 104-111
37. Schultz-Cherry, S. and Hinshaw, V.S. (1996) Influenza virus neuraminidase activates latent transforming growth factor β. J. Virol. 70, 8624-8629
38. Pahl, H.L. and Baeuerle, P.A. (1995) Expression of influenza virus hemagglutinin activates transcription factor NF-κB. J. Virol. 69, 1480-1484
39. Majde, J.A. (2000) Viral double-stranded RNA, cytokines, and the flu. J. Interferon Cytokine Res. 20, 259-272
40. Alexopoulou, L. et al. (2001) Recognition of double-stranded RNA and activation of NF-κB by Toll-like receptor 3. Nature 413, 732-738
41. Majde, J.A. et al. (1998) Spontaneous release of stable viral double-stranded RNA into the extracellular medium by influenza virus-infected MDCK epithelial cells: implications for the viral acute phase response. Arch. Virol. 143, 2371-2380
42. Garcia-Sastre, A. (2001) Inhibition of interferon-mediated antiviral responses by influenza A viruses and other negative-strand RNA viruses. Virology 279, 375-384
43. Garcia-Sastre, A. et al. (1998) Influenza A virus lacking the NS1 gene replicates in interferon-deficient systems. Virology 252, 324-330
44. Bergmann, M. et al. (2000) Influenza virus NS1 protein counteracts PKR-mediated inhibition of replication. J. Virol. 74, 6203-6206
45. Talon, J. et al. (2000) Activation of interferon regulatory factor 3 is inhibited by the influenza A virus NS1 protein. J. Virol. 74, 7989-7996
46. Kim, M.J. et al. (2002) Human influenza viruses activate an interferon-independent transcription of cellular antiviral genes: Outcome with influenza A virus is unique. Proc. Natl. Acad. Sci. U. S. A. 99, 10096-10101
47. Hayden, F.G. et al. (1998) Local and systemic cytokine responses during experimental human influenza A virus infection. Relation to symptom formation and host defense. J. Clin. Invest. 101, 643-649
48. Heui-Seo, S. et al. (2002) Lethal H5N1 influenza viruses escape host anti-viral cytokine responses. Nat. Med. 8, 950-954
49. Lamb, R.A. and Krug, R.M. (2001) Orthomyxoviridae: the viruses and their replication. In Virology (Fields, B.N., ed.), pp. 1487-1531, Lippincott - Raven
50. Chen, W. et al. (2001) A novel influenza A virus mitochondrial protein that induces cell death. Nat. Med. 7, 1306-1312